Skip to main content
. 2020 Jun 15;22(8):1147–1148. doi: 10.1093/europace/euaa065
Primary prevention of VT/VF in patients with ICM and LVEF ≤ 35% Class References
ICM substrate and ischaemic triggers for VT/VF must be evaluated when appropriate (coronary angiogram, functional ischaemic evaluation by nuclear scan, stress-echocardiography or MRI). graphic file with name euaa065ilf1.jpg 54 , 70 , 71
Cardiac MRI with a LGE can be considered in order to evaluate arrhythmogenic substrate including myocardial scarring to include in risk assessment and guide a possible VT ablation procedure. This investigation should be preferably performed before ICD implantation to avoid artefacts due to the presence of an implanted device. graphic file with name euaa065ilf2.jpg 369